Human ULBP-2/5/6 PE-conjugated Antibody Summary
Accession # Q9BZM5
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of ULBP-2/5/6 in HT1080 Human Cell Line by Flow Cytometry. HT1080 human fibrosarcoma cell line was stained with Mouse Anti-Human ULBP-2/5/6 PE-conjugated Monoclonal Antibody (Catalog # FAB1298P, filled histogram) or isotype control antibody (Catalog # IC003P, open histogram). View our protocol for Staining Membrane-associated Proteins.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, 2 to 8 °C as supplied.
Background: ULBP-2/5/6
ULBPs activate multiple signaling pathways in primary NK cells, resulting in the production of cytokines and chemokines. Binding of ULBPs ligands to NKG2D induces calcium mobilization and activation of the JAK2, STAT5, ERK and PI3K kinase/Akt signal transduction pathway. The name ULBP derives from the original identification of three proteins, ULBP-1, -2, and -3, as ligands for the human cytomegalovirus glycoprotein UL16; they were designated UL16 binding proteins (ULBP). The genes for ULBPs reside in a cluster of ten related genes, six of which encode potentially functional glycoproteins. ULBP-2 has also been described under the names RaeT1H (retinoic acid early transcript), NKG2DL2, and ALCAN-alpha. ULBP-5 also known as RaeT1G and ULBP-6 also known as RaeT1L. These proteins are distantly related to MHC class I proteins, but they possess only the alpha 1 and alpha 2 Ig-like domains, and they have no capacity to bind peptide or interact with beta 2‑microglobulin. Some family members, including ULBP-2, are anchored to the membrane via a GPI-linkage, whereas others have transmembrane domains. Engagement of NKG2D results in the activation of cytolytic activity and/or cytokine production by these effector cells. The ULBPs are expressed on some tumor cells and have been implicated in tumor surveillance. Over aa 26-217, ULBP-2 shares 92% and 95% aa sequence identity with the human ULBP-5 and ULBP-6, respectively.
- Cosman, D. et al. (2001) Immunity 14:123.
- Kubin, M. et al. (2001) Eur. J. Immunol. 31:1428.
- Sutherland, C. et al. (2002) J. Immunol. 168:671.
- Steinle, A. et al. (2001) Immunogenetics 53:279.
- Sutherland, C. et al. (2001) Immunol. Rev. 181:185.
- Pende, D. et al. (2002) Cancer Res. 62:6178.
- Radosavljevic, M. et al. (2002) Genomics 79:114.
- NKG2D and its Ligands (2002) www.RnDSystems.com.
Product Datasheets
Citations for Human ULBP-2/5/6 PE-conjugated Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
33
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma
Authors: Liu, J;Xing, L;Li, J;Wen, K;Liu, N;Liu, Y;Wu, G;Wang, S;Ogiya, D;Song, TY;Kurata, K;Penailillo, J;Morelli, E;Wang, T;Hong, X;Gulla, A;Tai, YT;Munshi, N;Richardson, P;Carrasco, R;Hideshima, T;Anderson, KC;
Nature communications
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Antitumor effects of NK cells expanded by activation pre?processing of autologous feeder cells before irradiation in colorectal cancer
Authors: Koh, EK;Lee, HR;Son, WC;Park, GY;Bae, J;Park, YS;
Oncology letters
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance
Authors: Dario Gerace, Quan Zhou, Jennifer Hyoje-Ryu Kenty, Adrian Veres, Elad Sintov, Xi Wang et al.
Cell Reports Medicine
-
gammadelta T cells are effectors of immunotherapy in cancers with HLA class I defects
Authors: NL de Vries, J van de Haa, V Veninga, M Chalabi, ME Ijsselstei, M van der Pl, J van den Bu, D Ruano, JG van den Be, JB Haanen, LJ Zeverijn, BS Geurts, GF de Wit, TW Battaglia, H Gelderblom, HMW Verheul, TN Schumacher, LFA Wessels, F Koning, NFCC de Miranda, EE Voest
Nature, 2023-01-11;613(7945):743-750.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for beta cell replacement
Authors: R Chimienti, T Baccega, S Torchio, F Manenti, S Pellegrini, A Cospito, A Amabile, MT Lombardo, P Monti, V Sordi, A Lombardo, M Malnati, L Piemonti
Cell Reports, 2022-09-27;40(13):111423.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma
Authors: Y Murayama, Y Kasahara, N Kubo, C Shin, M Imamura, N Oike, T Ariizumi, A Saitoh, M Baba, T Miyazaki, Y Suzuki, Y Ling, S Okuda, K Mihara, A Ogose, H Kawashima, C Imai
Translational Oncology, 2022-08-20;25(0):101521.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity
Authors: D Bernareggi, Q Xie, BC Prager, J Yun, LS Cruz, TV Pham, W Kim, X Lee, M Coffey, C Zalfa, P Azmoon, H Zhu, P Tamayo, JN Rich, DS Kaufman
Nature Communications, 2022-04-07;13(1):1899.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
Authors: T Seki, Y Shimizu, K Ishii, Y Takahama, K Kato, T Yano
Biomolecules, 2021-11-16;11(11):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
CD34(+) progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg(null) mice
Authors: Van der Meer JMR, de Jonge PKJD, van der Waart AB et al.
OncoImmunology
-
Rac1/ROCK-driven membrane dynamics promote natural killer cell cytotoxicity via granzyme-induced necroptosis
Authors: Y Zhu, J Xie, J Shi
Bmc Biology, 2021-07-30;19(1):140.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors
Authors: Ana L. Portillo, Richard Hogg, Sophie M. Poznanski, Eduardo A. Rojas, Niamh J. Cashell, Joanne A. Hammill et al.
iScience
-
Selection of tumor‑resistant variants following sustained natural killer cell‑mediated immune stress
Authors: Thibault Carré, Jerome Thiery, Bassam Janji, Stéphane Terry, Gwendoline Gros, Guillaume Meurice et al.
Oncology Reports
-
Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles
Authors: Benjamin H. Goldenson, Huang Zhu, YunZu Michele Wang, Naveen Heragu, Davide Bernareggi, Alessa Ruiz-Cisneros et al.
Frontiers in Immunology
-
The Oncoprotein SKI Acts as A Suppressor of NK Cell-Mediated Immunosurveillance in PDAC
Authors: V Ponath, M Frech, M Bittermann, R Al Khayer, A Neubauer, C Brendel, E Pogge von
Cancers (Basel), 2020-10-03;12(10):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells
Authors: Sofie H. Møller, Maiken Mellergaard, Mikkel Madsen, Amaia V. Bermejo, Stine D. Jepsen, Marie H. Hansen et al.
Frontiers in Immunology
-
Genetic and Molecular Basis of Heterogeneous NK Cell Responses against Acute Leukemia
Authors: DR Makanga, F Da Rin de, G David, C Willem, L Dubreuil, N Legrand, T Guillaume, P Peterlin, A Lebourgeoi, MC Béné, A Garnier, P Chevallier, K Gendzekhad, A Cesbron, K Gagne, B Clemenceau, C Retière
Cancers (Basel), 2020-07-16;12(7):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Enhanced activation of human NK cells by drug-exposed hepatocytes
Authors: Frank Fasbender, Martin Obholzer, Sarah Metzler, Regina Stöber, Jan G. Hengstler, Carsten Watzl
Archives of Toxicology
-
Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition
Authors: VA Jennings, GB Scott, AMS Rose, KJ Scott, G Migneco, B Keller, K Reilly, O Donnelly, H Peach, D Dewar, KJ Harrington, H Pandha, A Samson, RG Vile, AA Melcher, F Errington-
Mol. Ther., 2019-04-14;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-gamma
Authors: Masami Iwasa, Takeshi Harada, Asuka Oda, Ariunzaya Bat-Erdene, Jumpei Teramachi, Hirofumi Tenshin et al.
Oncotarget
-
Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells
Authors: Y Han, W Xie, DG Song, DJ Powell
J Hematol Oncol, 2018-07-06;11(1):92.
Species: Human
Sample Types: Whole Cells
Applications: CAR-T (Flow Cytometry) -
Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells
Authors: JRM Van Audena, J De Waele, E Marcq, J Van Loenho, E Lion, JMJ Van den Be, R Jesenofsky, A Masamune, G Roeyen, P Pauwels, F Lardon, M Peeters, ELJ Smits
Oncotarget, 2017-01-01;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand
PLoS Pathog, 2016-12-01;12(12):e1006015.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Gemcitabine inhibits immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein
Authors: Xiansheng Lin, Mei Huang, Fang Xie, Hangcheng Zhou, Ji Yang, Qiang Huang
Oncotarget
-
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts
Blood, 2016-03-24;127(23):2879-89.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain.
Authors: Lee S, Kang W, Yoon Y, Jin J, Song H, Her J, Kang S, Hwang Y, Kang K, Joo K, Nam D
BMC Cancer, 2015-12-24;15(1):1011.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia.
Authors: Parrish C, Scott G, Migneco G, Scott K, Steele L, Ilett E, West E, Hall K, Selby P, Buchanan D, Varghese A, Cragg M, Coffey M, Hillmen P, Melcher A, Errington-Mais F
Leukemia, 2015-03-27;29(9):1799-810.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Mutual Interaction between Human Multipotent Adult Progenitor Cells and NK Cells
Authors: Sandra A. Jacobs, Jeroen Plessers, Jef Pinxteren, Valerie D. Roobrouck, Catherine M. Verfaillie, Stefaan W. Van Gool
Cell Transplantation
-
The NKG2D ligand ULBP2 is specifically regulated through an invariant chain-dependent endosomal pathway.
Authors: Uhlenbrock F, Hagemann-Jensen M, Kehlet S, Andresen L, Pastorekova S, Skov S
J Immunol, 2014-07-14;193(4):1654-65.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Natural killer cell-mediated shedding of ULBP2.
Authors: Wang, Ruipeng, Sun, Peter D
PLoS ONE, 2014-03-10;9(3):e91133.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry, Neutralization -
Natural killer cell-produced IFN-gamma and TNF-alpha induce target cell cytolysis through up-regulation of ICAM-1.
Authors: Wang R, Jaw JJ, Jaw J, Stutzman NC, Stutzman N, Zou Z, Sun PD
J Leukoc Biol, 2011-11-01;91(2):299-309.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Vesicular Stomatitis Virus Infection Promotes Immune Evasion by Preventing NKG2D-Ligand Surface Expression.
Authors: Jensen H, Andresen L, Nielsen J, Christensen JP, Skov S
PLoS ONE, 2011-08-09;6(8):e23023.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Thermal- and Oxidative Stress Causes Enhanced Release of NKG2D Ligand-Bearing Immunosuppressive Exosomes in Leukemia/Lymphoma T and B Cells.
Authors: Hedlund M, Nagaeva O, Kargl D, Baranov V, Mincheva-Nilsson L
PLoS ONE, 2011-02-25;6(2):e16899.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Cytotoxicity of activated natural killer cells against pediatric solid tumors.
Authors: Cho D, Shook DR, Shimasaki N
Clin. Cancer Res., 2010-06-11;16(15):3901-9.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human ULBP-2/5/6 PE-conjugated Antibody
There are currently no reviews for this product. Be the first to review Human ULBP-2/5/6 PE-conjugated Antibody and earn rewards!
Have you used Human ULBP-2/5/6 PE-conjugated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image